Advertisement

Pharmacy

Faced with rising drug costs and shrinking reimbursements, hospitals must look to optimize every area of their organization. Because medications impact virtually every service line of the hospital, the pharmacy is powerful – and often under-utilized – center of innovation.

In a move to enhance its cancer drug pipeline, AstraZeneca agreed to pay up to $6.9 billion to a Japanese drugmaker for the shared rights to a new cancer drug, according to The Wall Street Journal.

Advertisement

North Chicago, Ill.-based AbbVie will lay off 178 workers from its Stemcentrx unit, which the drugmaker acquired for $5.8 billion three years ago, according to the San Francisco Business Times.

Advertisement